These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8069516)
1. Japanese pharmacopeial perspectives on particle measurement of injections. Fujishita O; Sendo T; Otsubo K; Aoyama T J Pharm Sci Technol; 1994; 48(3):148-54. PubMed ID: 8069516 [No Abstract] [Full Text] [Related]
2. A new coincidence model for single particle counters, Part I: Theory and experimental verification. Knapp JZ; Abramson LR J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513 [TBL] [Abstract][Full Text] [Related]
4. Application of improved standardization methods and instrumentation in the USP particulate test for SVI. Barber TA; Lannis MD; Williams JG; Ryan JF J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427 [TBL] [Abstract][Full Text] [Related]
5. Carleton's corner. Should the United States pharmacopeia define manufacturing process limits? Korczynski MS J Parenter Sci Technol; 1991; 45(2):76. PubMed ID: 2051259 [No Abstract] [Full Text] [Related]
6. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits. Parkins DA; Taylor AJ Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122 [TBL] [Abstract][Full Text] [Related]
7. General requirements for parenteral pharmaceuticals for the 21st USP revision--for the 21st Century. Barnstein CH J Parenter Drug Assoc; 1979; 33(5):287-9. PubMed ID: 259651 [No Abstract] [Full Text] [Related]
13. Standard particulate sets for visual inspection systems: their preparation, evaluation, and applications. Borchert SJ; Maxwell RJ; Davison RL; Aldrich DS J Parenter Sci Technol; 1986; 40(6):265-76. PubMed ID: 3819980 [No Abstract] [Full Text] [Related]
14. The pharmacopeial perspective in accelerating the development and availability of biologicals and biotechnological-derived products. Williams RL Dev Biol (Basel); 2002; 109():137-42. PubMed ID: 12434923 [No Abstract] [Full Text] [Related]
15. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2008 Feb; 73(35):9575-6. PubMed ID: 18677819 [TBL] [Abstract][Full Text] [Related]
16. Influencing standard setting. Robinson JR J Parenter Sci Technol; 1986; 40(3):77. PubMed ID: 3746573 [No Abstract] [Full Text] [Related]
17. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). Schepers U; Wätzig H J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114 [TBL] [Abstract][Full Text] [Related]
18. Development of a U.S.P. Type I glass for the pharmaceutical industry. Abendroth RP J Parenter Sci Technol; 1985; 39(3):112-3. PubMed ID: 3998968 [No Abstract] [Full Text] [Related]